Fund Selection & Suitability Policy
Sanriya Finvest Pvt. Ltd. · ARN-193359 · AMFI Registered Mutual Fund & Specialised Investment Fund (SIF) Distributor
Policy
Investor-first, consistent and auditable scheme selection — the philosophy, the process, the exclusions, and how portfolios are reviewed.
Sanriya Finvest Pvt. Ltd. · ARN-193359 · AMFI Registered Mutual Fund & Specialised Investment Fund (SIF) Distributor
The objective of this policy is to ensure investor-first, consistent and auditable scheme selection, in line with the SEBI Master Circular for Mutual Funds and the AMFI Code of Conduct and Due Diligence framework. Sanriya Finvest aims to identify suitable products, disclose the associated risks and costs transparently, and maintain documentary evidence supporting every scheme presented to an investor.
This policy applies to all employees, EUIN holders and sub-distributors (if applicable) of Sanriya Finvest Pvt. Ltd. who:
Three principles govern how we select:
Schemes are shortlisted and presented through a structured evaluation process that combines quantitative analysis with qualitative assessment. The objective is to help investors make informed decisions based on suitability rather than past returns alone.
Risk Profiling & Suitability PolicySchemes under SEBI or AMFI observation, schemes restricted or suspended for transactions, and schemes carrying a segregated portfolio are excluded from the shortlist.
We distribute:
Records relating to investor profiling, transactions and communications are maintained in accordance with applicable regulatory requirements and are available to the investor on request.
This is not a promise of high returns, and it is not a static document. It is a living guide that helps us stay rational when markets are not. Its purpose is to manage risk sensibly, pursue growth appropriate to each investor, and keep every decision rooted in care rather than convenience.
This policy is reviewed periodically, and on any change in the applicable regulatory guidelines. It is a working framework rather than a fixed prescription, and any investor may request a walkthrough of it during a review, or at any point when they feel uncertain.
Questions about this policy? Write to [email protected]
All documents